HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Excessive pancreatic polypeptide secretion — Clinical Guidelines

Overview

Excessive pancreatic polypeptide (PP) secretion is an uncommon condition characterized by elevated levels of PP beyond normal physiological ranges, often observed in association with pancreatic diseases or functional disorders but not well-defined by specific clinical symptoms alone 2.

Diagnosis

Elevated PP levels in blood tests are indicative but not diagnostic alone 2.

Imaging studies (e.g., CT, MRI) may help identify underlying pancreatic pathology 2.

Specific PP immunoassays are necessary for accurate measurement 3.

No standardized grading system exists for PP levels; clinical context is crucial 2.

Management

No specific first-line pharmacological treatments for excessive PP secretion are established 2.

Management focuses on addressing underlying causes such as pancreatic disorders 2.

Adjunctive supportive care may include dietary modifications and symptom management 2.

Special Populations

Limited evidence regarding excessive PP secretion in pregnancy, pediatrics, or elderly populations 2.

Comorbidities like chronic pancreatitis may influence PP levels but specific guidance is lacking 2.

Key Recommendations

Measure PP levels using validated immunoassays to assess for excessive secretion 3. (Evidence: Moderate)

Investigate and manage underlying pancreatic conditions contributing to elevated PP levels 2. (Evidence: Moderate)

Consider supportive care measures tailored to symptoms and underlying disease 2. (Evidence: Expert opinion)

References

1 Sithigorngul P, Panchan N, Vilaivan T, Sithigorngul W, Petsom A. Immunochemical analysis and immunocytochemical localization of crustacean hyperglycemic hormone from the eyestalk of Macrobrachium rosenbergii. Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology 1999. link00100-5) 2 Huang Y, Brown MR, Lee TD, Crim JW. RF-amide peptides isolated from the midgut of the corn earworm, Helicoverpa zea, resemble pancreatic polypeptide. Insect biochemistry and molecular biology 1998. link00007-1) 3 Méry J, Granier C, Juin M, Brugidou J. Disulfide linkage to polyacrylic resin for automated Fmoc peptide synthesis. Immunochemical applications of peptide resins and mercaptoamide peptides. International journal of peptide and protein research 1993. link

Excessive pancreatic polypeptide secretion